Americans now say they approve of free trade by 64%-27%, a margin of better than two to one. That's up from 57%-37% early in Trump's presidency, and 51%-41% near the end of...Politicsread more
Kudlow pointed to strong retail sales and low unemployment as signs that the U.S. economy remained strong.Marketsread more
The yield on the benchmark 10-year Treasury note briefly fell below the 2-year rate on Wednesday, a phenomenon in the bond market known as yield curve inversion, which is...Marketsread more
The MacBook Pro recall and its subsequent ban from flights underscores the increasing brand risk from problems with lithium-ion batteries.Technologyread more
Experts say the timing of Amazon executives' contributions to Rep. David Cicilline likely reflect the company's heightened urgency over growing regulatory scrutiny.Technologyread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
Coinbase security chief Philip Martin explains, "Possession of a key is possession of your currency. What that means is that you can't revoke a cryptocurrency key, if that key...Technologyread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
The Supreme Court could strike down the constitutionality of the Consumer Financial Protection Bureau, an agency Elizabeth Warren has likened to her child and which Justice...2020 Electionsread more
Bianco Research's James Bianco suggests Wall Street is desperately looking for a signal that a 50 basis point cut is coming next month.Trading Nationread more
Check out the companies making headlines midday Monday:
Boeing — Shares of Boeing dropped 4.44% after Bank of America Merrill Lynch cut its rating to neutral from buy after Boeing announced it plans to cut production of the jet on Friday. The bank expects delays with 737 will last six to nine months.
Southwest Airlines — The airline fell 2.46% after Raymond James downgraded it to hold from buy, citing concerns that Boeing jet groundings could last through peak summer travel. Southwest has 34 Max jets which account for roughly 4 percent of the airline's passenger capacity.
General Electric — GE tumbled 5.19% after J.P. Morgan's Stephen Tusa downgraded the stock underweight from neutral and cut his 12-month price target to $5 from $6. "We believe many investors are underestimating the severity of the challenges and underlying risks at GE, while overestimating the value of small positives," wrote Tusa in a note to clients.
Sony — Shares of Sony surged 7.3% and ended the day little changed after Reuters reported that Daniel Loeb's Third Point is building a stake in the company and plans to push for changes. Third Point is reportedly raising an investment vehicle to generate between $500 million and $1 billion to continue buying Sony shares. This is the second time in 6 years that the hedge fund has targeted Sony.
J. Alexander Holdings — The Southern restaurant chain's stock rallied more than 8% after activist investor Ancora Advisors announced an offer to take the company private for $11.75 per share. The offering represented more than a 12% premium to Friday's closing price.
Symantec — Symantec jumped more than 5% after an analyst at Goldman Sachs upgraded the stock to buy from neutral, highlighting an "undemanding" valuation and a "to sustained growth in current billings."
AMC Entertainment — Shares of the movie theater company surged 92u% after B. Riley FBR upgraded them to buy from neutral. The firm cited a strong line-up of films coming out in the spring and summer, which includes Marvel's "Avengers: Endgame."
2U — Shares of the educational technology company dropped about 3.4% after 2U announced it is purchasing Trilogy Education Services for $750 million.
United Therapeutics —United Therapeutics fell around 5.7% after the company announced its clinical study of esuberaprost tablets did not meet its primary endpoint. The biotechnology company is discontinuing product development for the pulmonary arterial hypertension treatment.